aboratory tests to support the clinical diagnosis of anaphylaxis in healthy volunteers

Not Applicable

Recruiting

• Conditions: anaphylaxis; D000707

• Registration Number: JPRN-jRCT1031210569
• Lead Sponsor: Takazawa Tomonori

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-01-21
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

1) A volunteer who is 20 years or older
2) A volunteer whose written consent has been obtained regarding participation in this study

Exclusion Criteria

1)A pregnant woman /A patient who has a possibility of pregnancy
2)A volunteer taking beta-blocker
3)A volunteer taking steroid
4)A volunteer with a history of perioperative anaphylaxis
5)A volunteer who cannot stop taking antihistamines

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Seeking the optimum concentrations of drugs for in vitro tests.

Secondary Outcome Measures

Name	Time	Method
Exploring the methods which improve the accuracies of in vitro tests.